Lv69
2433 积分 2020-07-02 加入
Efficacy and safety of cemdisiran siRNA in myasthenia gravis (NIMBLE): a double-blind, randomised, placebo-controlled, phase 3 trial
3天前
已完结
IgA Nephropathy
3天前
已完结
Chronic Kidney Disease
3天前
已完结
Lupus nephritis
3天前
已完结
The pathogenesis of IgA nephropathy and implications for treatment
3天前
已完结
IgA Nephropathy
3天前
已完结
Canonical and non-canonical roles of complement in atherosclerosis
3天前
已完结
Complement
3天前
已完结
The complement system: Biology, pathology, and therapeutic interventions
3天前
已完结
Complement: The Road Less Traveled
3天前
已完结